CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants

NCT07350837 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Highly Sensitized Patients Awaiting Kidney Transplant

Interventions

DRUG: AZD0120

Sponsor

Tongji Hospital